Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Metformin may help treat neuroendocrine tumors.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

5% minoxidil works better for hair growth than 1% minoxidil.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.